Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

Total Assets Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual total assets in 2023 was 324.4 Million INR , down -77.21% from previous year.
Transgene Biotek Limited's latest quarterly total assets in 2023 FY was 324.4 Million INR , down -77.21% from previous quarter.
Transgene Biotek Limited reported annual total assets of 1.42 Billion INR in 2022, down -3.22% from previous year.
Transgene Biotek Limited reported annual total assets of 1.47 Billion INR in 2021, down -6.24% from previous year.
Transgene Biotek Limited reported quarterly total assets of 1.42 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Transgene Biotek Limited reported quarterly total assets of 324.4 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Total Assets of Transgene Biotek Limited (2023 - 2006)

Year	Total Assets	Total Assets Growth
2023	324.4 Million INR	-77.21%
2022	1.42 Billion INR	-3.22%
2021	1.47 Billion INR	-6.24%
2020	1.56 Billion INR	-5.92%
2019	1.66 Billion INR	-5.55%
2018	1.76 Billion INR	-5.36%
2017	1.86 Billion INR	-5.81%
2016	1.98 Billion INR	-36.72%
2015	3.12 Billion INR	-8.96%
2014	3.43 Billion INR	-4.07%
2013	3.58 Billion INR	-2.79%
2012	3.68 Billion INR	0.79%
2011	3.65 Billion INR	51.25%
2010	2.41 Billion INR	82.61%
2009	1.32 Billion INR	0.51%
2008	1.31 Billion INR	1.72%
2007	1.29 Billion INR	4.85%
2006	1.23 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2023 FY	324.4 Million INR	-77.21%
2023 Q2	1.42 Billion INR	0.0%
2023 Q4	324.4 Million INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q1	- INR	-100.0%
2022 Q4	1.42 Billion INR	0.0%
2022 FY	1.42 Billion INR	-3.22%
2022 Q1	- INR	-100.0%
2022 Q2	347.51 Million INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q4	1.47 Billion INR	0.0%
2021 Q2	1.51 Billion INR	0.0%
2021 FY	1.47 Billion INR	-6.24%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	1.56 Billion INR	-5.92%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q2	1.61 Billion INR	0.0%
2020 Q4	1.56 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 FY	1.66 Billion INR	-5.55%
2019 Q2	1.71 Billion INR	0.0%
2019 Q4	1.66 Billion INR	0.0%
2018 FY	1.76 Billion INR	-5.36%
2018 Q1	- INR	0.0%
2018 Q4	1.76 Billion INR	0.0%
2017 FY	1.86 Billion INR	-5.81%
2016 FY	1.98 Billion INR	-36.72%
2015 FY	3.12 Billion INR	-8.96%
2014 FY	3.43 Billion INR	-4.07%
2013 FY	3.58 Billion INR	-2.79%
2012 FY	3.68 Billion INR	0.79%
2012 Q1	3.9 Billion INR	0.0%
2012 Q2	7.63 Billion INR	95.6%
2012 Q4	3.68 Billion INR	-53.26%
2012 Q3	7.88 Billion INR	3.24%
2011 FY	3.65 Billion INR	51.25%
2010 FY	2.41 Billion INR	82.61%
2009 FY	1.32 Billion INR	0.51%
2008 FY	1.31 Billion INR	1.72%
2007 FY	1.29 Billion INR	4.85%
2006 FY	1.23 Billion INR	0.0%

Peer Total Assets Comparison of Transgene Biotek Limited

Name	Total Assets	Total Assets Difference
Alfavision Overseas (India) Limited	1.78 Billion INR	81.832%
Biocon Limited	560.7 Billion INR	99.942%
Blue Jet Healthcare Limited	10.58 Billion INR	96.936%
Concord Biotech Limited	17 Billion INR	98.093%
Dishman Carbogen Amcis Limited	95.81 Billion INR	99.661%
FERMENTA BIOTECH LIMITED	5.47 Billion INR	94.078%
GENOMIC VALLEY BIOTECH LIMITED	43.33 Million INR	-648.564%
Lyka Labs Limited	1.56 Billion INR	79.301%
Panacea Biotec Limited	12.4 Billion INR	97.385%
SAMSRITA LABS LIMITED	155.51 Million INR	-108.602%
Servoteach Industries Limited	1591.00 INR	-20389780.578%
SMS Lifesciences India Limited	3.9 Billion INR	91.693%
Supriya Lifescience Limited	9.21 Billion INR	96.479%
Syngene International Limited	61.51 Billion INR	99.473%
TAKE Solutions Limited	881.05 Million INR	63.18%
Titan Biotech Limited	1.56 Billion INR	79.282%
Vanta Bioscience Limited	853.96 Million INR	62.012%